Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Deborah Collyar: What's In It for Patients?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Advertisement

Advertisement




Jan
16
Today In Oncology
Can a Genetic Variant Affect the Efficacy of Abiraterone
Triplet Therapy Demonstrates Superior Progression-Free Survival in First-Line dMMR-MSI-H Metastatic Colorectal Cancer
Can Multimodal AI Models Predict Distant Recurrence Risk in Patients With Early Breast Cancer
HER2-Positive Gastroesophageal Cancer Zanidatamab Plus Chemotherapy Prolongs Progression-Free Survival
Improved Contralateral Breast Cancer Risk Knowledge With Personalized Counseling Tool
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo